Hospitals and Clinics Segment to Dominate Middle East & Africa Defibrillator Market during 2019–2028

According to a new market research study on “Middle East & Africa Defibrillator Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product and End User,” is expected to reach US$ 688.80 million by 2028 from US$ 529.01 million in 2021. The market is estimated to grow at a CAGR of 3.8% from 2021 to 2028. Strategies by major market players to expand presence in emerging markets is the major factor driving the growth of the Middle East & Africa defibrillator market. However, cost and performance issues related to implantable and automated external defibrillators may hinder the growth of Middle East & Africa defibrillator market. The report provides trends prevailing in the Middle East & Africa defibrillator market along with the drivers and restraints pertaining to the market growth.

The increasing number of COVID-19 cases and poor healthcare infrastructure, especially in Africa, has put a massive strain on the healthcare industry. The Middle East & Africa saw an increase in demand for defibrillators as an essential device for the care of COVID-19 patients but the lack of supply in the region by local players and demand from other regions for defibrillators adversely affected the market. Donations from other regions and supply from companies outside the region aided in the demand for defibrillators in the region but fell short, especially in Africa.

The Middle East & Africa defibrillator market is segmented into product, end user, and country. Based on product, the market is segmented into implantable cardioverter defibrillator (ICD) and external. In 2020, the implantable cardioverter defibrillator segment held the largest share Middle East & Africa defibrillator market. The implantable cardioverter defibrillator is further sub-segmented into transvenous ICD and subcutaneous ICD. The transvenous ICD segment accounts for largest market share in the 2020. Similarly, the external segment is sub-segmented into manual, wearable, and fully automated external defibrillators. In 2020, the manual segment held the largest share of the market. Based on end user, the Middle East & Africa defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities. The hospitals and clinics segment held the largest share of the market in 2020. Similarly, based on country, the market is segmented into Saudi Arabia, South Africa, UAE, and  rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2020. 

Abbott; Boston Scientific Corporation; Koninklijke Philips N.V.; Medtronic; Nihon Kohden Corporation; Shenzhen Mindray Biomedical Electronics Co., Ltd; and ZOLL MEDICAL CORPORATION are among the leading companies in the Middle East & Africa defibrillator market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ZOLL Medical Corporation announced a launch of remote view technology on the X Series monitor/defibrillator developed for EMS agencies.

Middle East & Africa Defibrillator Market, By Country, 2020 and 2028 (%) 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com